What Is Blinding, and When Does a Study Actually Need It?

Who Should Not Know Which Condition a Participant Received?

You randomly assign participants to two interventions. The groups were created properly. Does that mean the comparison is now protected from bias?

Not necessarily.

Participants may behave differently if they know which condition they received. Intervention providers may treat participants differently. An assessor who knows that a student received the “innovative” program might unconsciously judge an ambiguous performance more favorably.

Blinding, also called masking in some fields, is intended to reduce particular biases that can arise when people know study assignments. But who should be blinded, whether blinding is feasible, and whether it matters depend on what those people can influence.

Blinding Matters When Knowledge of Assignment Could Influence the Study

Blinding Protects the Study After Assignments Become Known

The National Institute on Aging defines masking or blinding as keeping relevant parties unaware of treatment assignments. Cochrane similarly describes blinding as mechanisms intended to keep participants, carers, and trial personnel unaware of the intervention received.

Different fields sometimes prefer different terminology. “Blinding” remains common, while “masking” is preferred in some areas. The methodological idea is the same: restrict knowledge of assignment when that knowledge could influence the study.

Blinding and random assignment solve different problems

Random assignment determines which condition a participant receives using a chance mechanism. It primarily protects against systematic baseline allocation based on participant characteristics or investigator choice.

Blinding becomes relevant once assignments have been made. It addresses what may happen because participants, providers, assessors, or others know those assignments.

A study can therefore be randomized but unblinded. It can also use blinded outcome assessment in a nonrandomized study.

Participants can sometimes be blinded

Participant blinding means participants do not know which study condition they received.

This may matter when expectations influence behavior, adherence, symptom reporting, use of additional interventions, or other outcomes.

In drug trials, a placebo may sometimes make participant blinding feasible by making the control condition resemble the intervention. In other contexts, participant blinding may be difficult or impossible.

A student usually knows whether they attended a new teaching workshop. A patient generally knows whether they underwent surgery. A teacher knows which instructional approach they are delivering.

The impossibility of participant blinding does not automatically invalidate such studies. It changes which potential biases need to be considered and what alternative safeguards may be possible.

People delivering the intervention may also influence outcomes

Those delivering an intervention can alter the experience of participants if they know which condition they are providing.

An instructor enthusiastic about a new teaching method might provide extra encouragement, additional explanations, or more attention. A clinician might manage participants differently because of their assigned treatment.

Sometimes this knowledge is unavoidable. An instructor cannot realistically be unaware of which curriculum they are teaching.

Researchers should then ask whether standardized procedures, training, protocol monitoring, or other safeguards can reduce differential treatment beyond what the study conditions themselves require.

Outcome assessor blinding can matter even when participants cannot be blinded

This is one of the most useful distinctions in applied research.

Suppose students and teachers necessarily know which teaching method was used. The people scoring students' final essays may not need to know.

If essays can be coded so assessors cannot identify the study condition, blinded outcome assessment may reduce the possibility that expectations influence subjective scoring.

Cochrane specifically treats awareness of intervention assignment by outcome assessors as an important consideration in bias arising from outcome measurement. Blinding is particularly relevant when assessment involves judgment.

The importance of blinding depends on the outcome

Not all outcomes are equally susceptible to knowledge of treatment assignment.

Consider two outcomes in the same study:

• a participant's self-reported satisfaction with an intervention;
• an automatically recorded completion time from a computer system.

If participants know which intervention they received, that knowledge could plausibly influence their satisfaction rating. It is less obvious how the same knowledge would alter an automatically logged completion time, although behavior itself could still change because of expectations.

Cochrane emphasizes that risk of bias from lack of blinding can differ by outcome. A study should therefore not be classified globally as “biased because it was unblinded” without asking what knowledge could plausibly influence each outcome.

Blinding is not the same as allocation concealment

This distinction is easy to miss because both involve withholding information about treatment assignments.

Allocation concealment occurs before or at assignment. It prevents people enrolling participants from knowing the upcoming allocation sequence and using that knowledge to influence who enters which condition.

Blinding concerns knowledge of the assigned intervention during subsequent study conduct, measurement, or analysis.

Cochrane explicitly warns that these concepts are often confused. A trial can conceal allocation successfully but then conduct the intervention openly. Conversely, saying that outcome assessors were blinded does not tell you whether the allocation sequence was concealed during recruitment.

Blinding is sometimes impossible

Some interventions reveal themselves.

Participants know whether they received psychotherapy, attended an educational workshop, used a new software interface, participated in an exercise program, or underwent surgery.

Researchers should not claim blinding that could not plausibly have occurred.

Instead, identify who could feasibly remain unaware. Perhaps the outcome assessor can be blinded. Perhaps automated outcome measurement can reduce discretionary assessment. Perhaps standardized intervention protocols can reduce differential behavior by personnel.

The design question becomes: which pathways from knowledge of assignment to biased results can reasonably be blocked?

Attempted blinding may not remain successful

Even when researchers intend to blind participants or personnel, features of the intervention may reveal the assignment.

A medication may have distinctive side effects. A sham intervention may feel noticeably different. Participants may discuss their conditions with assessors. Documents sent for supposedly blinded assessment may contain identifying information.

Cochrane notes that an attempt to blind does not ensure successful blinding in practice.

Researchers should therefore describe what was actually done rather than treating the label “blinded” as self-explanatory.

The familiar single-, double-, and triple-blind labels can be ambiguous

What does “double-blind” mean?

Participants and clinicians? Participants and assessors? Investigators and analysts?

Different publications have used these labels inconsistently. Cochrane therefore cautions that broad terms such as “double blind” make it difficult to determine exactly who was unaware of treatment assignment.

A more informative report states explicitly who was blinded and how.

The question of whether single-, double-, and triple-blinding labels are actually useful therefore deserves separate treatment.

Blinding does not automatically eliminate bias

A blinded assessor can still use an unreliable instrument. Participants can still drop out. Intervention delivery can still differ from protocol. Missing outcomes can still bias results. Researchers can still make inappropriate analytical choices.

Blinding addresses particular mechanisms of bias. It is not a general quality certificate.

Likewise, an unblinded study is not automatically invalid. The likely effect of awareness depends on who knew, what they could influence, and the outcome being considered.

Blinding may also reduce contamination and deviations from intended intervention

Knowledge of assignment can sometimes influence whether participants or providers cross between conditions or seek additional interventions.

Cochrane notes that successful blinding may reduce deviations from intended interventions, including contamination and switches to non-protocol interventions.

This can be especially relevant when participants in one condition can access elements of another. The broader problem of contamination between groups may therefore intersect with blinding, although blinding is only one possible preventive strategy.

When You Cannot Blind the Participants but Can Still Blind the Outcome Assessment

Now imagine the primary outcome were instead students' self-reported satisfaction with the teaching method. The participant is also the outcome assessor for that outcome. If students know their condition, the satisfaction measure cannot be blinded in the same way.

The same study can therefore have different blinding-related risks for different outcomes.

Common Misunderstandings About Blinding

Decide Who Needs Blinding by Asking What Their Knowledge Could Change

Instead of beginning with “How do I make this double-blind?”, identify the people who interact with the study and ask what could happen if each person knew the assigned condition.

That produces a more useful design decision.

Before Deciding Whether Your Study Needs Blinding

Frequently Asked Questions About Blinding in Research

Blind the People Whose Knowledge Could Bias the Comparison

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.